🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objectives of this study are to characterize the disease impact, the di...
Status
Terminated
Location
Children's Hospital of Pittsburgh of UPMC
Start Date
2022-07-25
Trial ID
NCT04812106
Treatments Being Tested
Patients suffering from cancer often experience a loss of muscle mass and s...
Status
Unknown
Location
Hector-Center for Nutrition, Exercise and Sports
Start Date
2016-12
Trial ID
NCT03151291
The aim of this study was to evaluate efficacy and safety of Alpha Lipoic A...
Status
Completed
Location
Multiple Locations
Start Date
2016-01
Trial ID
NCT03953248
Treatments Being Tested
Cardiovascular disease (CVD) is the leading cause of Taiwan. L-carnitine (L...
Status
Completed
Location
Taichung Verterans General Hospital
Start Date
2013-01
Trial ID
NCT01819701
The main goal of this study is to evaluate the effects of triheptanoin vers...
Status
Active Not Recruiting
Location
General University Hospital in Prague-GUH (Všeobecná fakultní nemocnice v Praze- VFN)
Start Date
2023-02-28
Trial ID
NCT05933200
Treatments Being Tested
The primary objective of this study is to assess the long-term safety, incl...
Status
Active Not Recruiting
Location
Phoenix Children's Hospital
Start Date
2021-11-30
Trial ID
NCT04632953
Treatments Being Tested
The role of the combination therapy of hydroxyurea and L-Carnitine was stud...
Status
Completed
Location
Safaa A A Khaled
Start Date
2017-01-10
Trial ID
NCT05081349
Expanded access may be provided for qualified patients who have limited tre...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT03773770
Treatments Being Tested
The primary objective of this study is to evaluate the long-term safety and...
Status
Completed
Location
University of California San Francisco
Start Date
2014-12-09
Trial ID
NCT02214160
Treatments Being Tested